Objective: To determine whether DAZL1 is expressed in human fetal ovarian t
issue.
Design: The presence of DAZL1 expression was determined by reverse transcri
ptase polymerase chain reaction (RT-PCR).
Setting: Academic tertiary care medical center and research unit of univers
ity.
Patient(s): Five female abortuses between the 19th and 22nd week of gestati
onal age.
Intervention(s): Fetal ovarian tissues were collected immediately after the
cessation of the heart beat.
Main Outcome Measure(s): The product of RT-PCR.
Result(s): DAZL1 expression was detected in all five samples.
Conclusion(s): DAZL1 is not only expressed in human testes but also in ovar
ies. It may play a role in germ cell survival and gonad development in both
sexes. American Society for Reproductive Medicine.